Highly parallelized droplet cultivation and prioritization on antibiotic producers from natural microbial communities

  1. Lisa Mahler
  2. Sarah P Niehs
  3. Karin Martin
  4. Thomas Weber
  5. Kirstin Scherlach
  6. Christian Hertweck
  7. Martin Roth
  8. Miriam A Rosenbaum  Is a corresponding author
  1. Leibniz Institute for Natural Products Research and Infection Biology - Hans-Knöll-Institute, Germany

Abstract

Antibiotics from few culturable microorganisms have saved millions of lives since the 20th century. But with resistance formation, these compounds become increasingly ineffective, while the majority of microbial and with that chemical compound diversity remains inaccessible for cultivation and exploration. Culturing recalcitrant bacteria is a stochastic process. But conventional methods are limited to low throughput. By increasing (i) throughput and (ii) sensitivity by miniaturization, we innovate microbiological cultivation to comply with biological stochasticity. Here, we introduce a droplet-based microscale-cultivation system, which is directly coupled to a high-throughput screening for antimicrobial activity prior to strain isolation. We demonstrate that highly parallelized in-droplet cultivation starting from single cells results in the cultivation of yet uncultured species and a significantly higher bacterial diversity than standard agar plate cultivation. Strains able to inhibit intact reporter strains were isolated from the system. A variety of antimicrobial compounds were detected for a selected potent antibiotic producer.

Data availability

- Amplicon sequence data were deposited to NCBI under the BioProject accession numbers PRJNA623865. For isolated axenic strains, 16S rRNA gene sequences were deposited to GenBank under the accession numbers MT320111 - MT320533.- Source data, encompassing numerical and or taxonomical data and R-analysis files, are provided as RData objects and R scripts for graphs: Fig 2ab, Fig 3abc, Fig 5, Fig 6.Figures 1ab, 4 and 7 do not contain analyzed experimental data but depict workflows and overview information.

The following data sets were generated

Article and author information

Author details

  1. Lisa Mahler

    Bio Pilot Plant, Leibniz Institute for Natural Products Research and Infection Biology - Hans-Knöll-Institute, Jena, Germany
    Competing interests
    The authors declare that no competing interests exist.
  2. Sarah P Niehs

    Biomolecular Chemistry, Leibniz Institute for Natural Products Research and Infection Biology - Hans-Knöll-Institute, Jena, Germany
    Competing interests
    The authors declare that no competing interests exist.
  3. Karin Martin

    Bio Pilot Plant, Leibniz Institute for Natural Products Research and Infection Biology - Hans-Knöll-Institute, Jena, Germany
    Competing interests
    The authors declare that no competing interests exist.
  4. Thomas Weber

    Bio Pilot Plant, Leibniz Institute for Natural Products Research and Infection Biology - Hans-Knöll-Institute, Jena, Germany
    Competing interests
    The authors declare that no competing interests exist.
  5. Kirstin Scherlach

    Department of Biomolecular Chemistry, Leibniz Institute for Natural Products Research and Infection Biology - Hans-Knöll-Institute, Jena, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Christian Hertweck

    Department of Biomolecular Chemistry, Leibniz Institute for Natural Products Research and Infection Biology - Hans-Knöll-Institute, Jena, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. Martin Roth

    Bio Pilot Plant, Leibniz Institute for Natural Products Research and Infection Biology - Hans-Knöll-Institute, Jena, Germany
    Competing interests
    The authors declare that no competing interests exist.
  8. Miriam A Rosenbaum

    Bio Pilot Plant, Leibniz Institute for Natural Products Research and Infection Biology - Hans-Knöll-Institute, Jena, Germany
    For correspondence
    miriam.rosenbaum@leibniz-hki.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4566-8624

Funding

Thuringian Ministry of Eduction, Scienc and Culture (13008-715)

  • Lisa Mahler
  • Karin Martin
  • Martin Roth

Thuringian Ministry of Economy, Labor and Technology (2014FE9037)

  • Lisa Mahler
  • Thomas Weber
  • Martin Roth

German Center for Infection Research DZIF (TTU 09.811)

  • Lisa Mahler
  • Karin Martin

Deutsche Forschungsgemeinschaft (GSC 214)

  • Lisa Mahler

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2021, Mahler et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,978
    views
  • 907
    downloads
  • 54
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Lisa Mahler
  2. Sarah P Niehs
  3. Karin Martin
  4. Thomas Weber
  5. Kirstin Scherlach
  6. Christian Hertweck
  7. Martin Roth
  8. Miriam A Rosenbaum
(2021)
Highly parallelized droplet cultivation and prioritization on antibiotic producers from natural microbial communities
eLife 10:e64774.
https://doi.org/10.7554/eLife.64774

Share this article

https://doi.org/10.7554/eLife.64774

Further reading

    1. Ecology
    2. Microbiology and Infectious Disease
    Tom Clegg, Samraat Pawar
    Research Article Updated

    Predicting how species diversity changes along environmental gradients is an enduring problem in ecology. In microbes, current theories tend to invoke energy availability and enzyme kinetics as the main drivers of temperature-richness relationships. Here, we derive a general empirically-grounded theory that can explain this phenomenon by linking microbial species richness in competitive communities to variation in the temperature-dependence of their interaction and growth rates. Specifically, the shape of the microbial community temperature-richness relationship depends on how rapidly the strength of effective competition between species pairs changes with temperature relative to the variance of their growth rates. Furthermore, it predicts that a thermal specialist-generalist tradeoff in growth rates alters coexistence by shifting this balance, causing richness to peak at relatively higher temperatures. Finally, we show that the observed patterns of variation in thermal performance curves of metabolic traits across extant bacterial taxa is indeed sufficient to generate the variety of community-level temperature-richness responses observed in the real world. Our results provide a new and general mechanism that can help explain temperature-diversity gradients in microbial communities, and provide a quantitative framework for interlinking variation in the thermal physiology of microbial species to their community-level diversity.

    1. Cell Biology
    2. Microbiology and Infectious Disease
    Clément Mazeaud, Stefan Pfister ... Laurent Chatel-Chaix
    Research Article

    Zika virus (ZIKV) infection causes significant human disease that, with no approved treatment or vaccine, constitutes a major public health concern. Its life cycle entirely relies on the cytoplasmic fate of the viral RNA genome (vRNA) through a fine-tuned equilibrium between vRNA translation, replication, and packaging into new virions, all within virus-induced replication organelles (vROs). In this study, with an RNA interference (RNAi) mini-screening and subsequent functional characterization, we have identified insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) as a new host dependency factor that regulates vRNA synthesis. In infected cells, IGF2BP2 associates with viral NS5 polymerase and redistributes to the perinuclear viral replication compartment. Combined fluorescence in situ hybridization-based confocal imaging, in vitro binding assays, and immunoprecipitation coupled to RT-qPCR showed that IGF2BP2 directly interacts with ZIKV vRNA 3’ nontranslated region. Using ZIKV sub-genomic replicons and a replication-independent vRO induction system, we demonstrated that IGF2BP2 knockdown impairs de novo vRO biogenesis and, consistently, vRNA synthesis. Finally, the analysis of immunopurified IGF2BP2 complex using quantitative mass spectrometry and RT-qPCR revealed that ZIKV infection alters the protein and RNA interactomes of IGF2BP2. Altogether, our data support that ZIKV hijacks and remodels the IGF2BP2 ribonucleoprotein complex to regulate vRO biogenesis and vRNA neosynthesis.